Dow climbs 400 points as COVID-19 drug hopes outweigh economic pain

Dow climbs 400 points as COVID-19 drug hopes outweigh economic pain

Reuters US equities soared on Wednesday as traders gained new hope from a successful coronavirus drug trial.Gilead announced Wednesday morning its remdesivir compound succeeded in a key trial. Additional information on the study will be rele…
Read More